Shares of Zentek Ltd. (CVE:ZEN - Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$1.67 and traded as low as C$1.39. Zentek shares last traded at C$1.47, with a volume of 42,587 shares.
Zentek Stock Performance
The business has a 50-day moving average price of C$2.01 and a 200-day moving average price of C$1.67. The firm has a market capitalization of C$154.10 million, a price-to-earnings ratio of -14.15 and a beta of 0.77. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97.
Insider Buying and Selling
In other Zentek news, Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of the company's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of C$2.20, for a total value of C$33,000.00. Insiders own 6.01% of the company's stock.
About Zentek
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Featured Articles
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
